Amrutanjan Health Care Limited has informed stock exchanges about receiving a tax demand order of Rs 24.28 lakh under the CGST/IGST Act 2017, as disclosed in a regulatory filing dated March 18, 2026.

Order Details and Authority

The order was issued by the Additional Commissioner of Central Excise & Customs (Appeals-II) on March 17, 2026, under sections 73 & 74 of the CGST Act 2017. The company has submitted the required details pursuant to Regulation 30 of SEBI Listing Regulations and SEBI Circular dated July 13, 2023.

Nature of Alleged Violations

The first appellate authority has passed an order for reversal of input tax credit on account of GSTR2A mismatch and questioned the eligibility of input tax credit for the financial years 2020-21 to 2021-22. The total tax demand amounts to Rs 24.28 lakh along with applicable interest and penalty.

Company's Response and Position

Amrutanjan Health Care has expressed disagreement with the order and stated it will take appropriate action for rectification or reversal. The company maintains that it availed input tax credit after fulfilling all conditions as per GST law provisions. Based on the merits of the case, the company plans to file an appeal against the order.

Financial Impact Assessment

According to the company's assessment, this order does not have any major financial implications on its operations. The management has indicated confidence in its position regarding the proper availment of input tax credit in compliance with GST regulations.

The disclosure was signed by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer, ensuring compliance with regulatory requirements under SEBI Listing Regulations.

Amrutanjan Health Care Limited has issued a comprehensive response to a surveillance query from the National Stock Exchange of India regarding a news article and court order, clarifying the company's position on recent developments.

NSE Surveillance Query Response

The company addressed three specific queries raised by NSE in its letter dated 17 March 2026. In response to questions about potential negotiations or events, Amrutanjan Health Care clarified that no such negotiations were taking place. The news item referenced in the NSE letter pertains to an old case titled Writ Petition No. 35484 of 2005, which has now been decided by the Hon'ble Madras High Court.

Court Order Details

The company received the copy of the court order late on 17 March 2026. As required under SEBI regulations, Amrutanjan Health Care provided detailed information about the legal proceedings in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Legal Case Information

Business Impact Assessment

The company has emphasized that the court decision will not impact its business and operations. Key points regarding the impact include:

• The matter has been disclosed as contingent liability in annual reports
• No material impact on financial or operational activities
• Company maintains regular compliance with disclosure requirements
• News articles contain certain factually incorrect information

Regulatory Compliance

Amrutanjan Health Care confirmed its commitment to regulatory compliance, stating that the company is regular and prompt in providing information to exchanges. The response was signed by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer, and digitally authenticated on 18 March 2026.

The company is actively evaluating the matters and reserves its right to pursue all available legal remedies, both regarding the case outcome and news articles containing incorrect information. The company has affirmed its full commitment to complying with all applicable regulatory requirements and will continue taking necessary steps to ensure adherence.